申请人:Nauchno-Issledovatelsky Institut Farmakologii Rossiiskoi Akademii Meditsinskikh Nauk
公开号:US06376666B1
公开(公告)日:2002-04-23
2-mercaptobenzimidazole derivatives of the general formula
wherein: N=0,2,3; R-hydrogen atom, aralkyls; R1-lower alkyls, alkenyls, dialkylamino, a saturated amine monocyclic residue which may contain an additional heteroatom; R2 and R3 are equal or different and stand for hydrogen atoms, lower alkyls, alkoxy in various positions, and their pharmaceutically acceptable salts, according to the results of pharmacological research study exhibit a pronounced anxiolytic, sedative, antiischemia and antiarrhythmia effect and have certain advantages over popular clinic preparations. These can find a wide variety of application for treatment of patients suffering from various mental derangements and heart ischemia.
2-巯基苯并咪唑衍生物的一般公式如下:其中:N=0,2,3;R-氢原子,芳基烷基;R1-较低的烷基,烯烃基,二烷基胺,可能含有额外杂原子的饱和胺单环残基;R2和R3相等或不同,代表氢原子,较低的烷基,在不同位置的烷氧基,以及它们的药用盐,根据药理研究结果表现出明显的抗焦虑、镇静、抗缺血和抗心律失常效果,并且相对于流行的临床制剂具有一定优势。这些可以在治疗患有各种心理紊乱和心脏缺血的患者中找到广泛的应用。